Share on StockTwits

Baxano Surgical (NASDAQ:BAXS) CEO Kenneth Michael Reali purchased 10,000 shares of the company’s stock in a transaction that occurred on Friday, August 15th. The shares were purchased at an average cost of $0.38 per share, with a total value of $3,800.00. Following the completion of the acquisition, the chief executive officer now directly owns 141,128 shares of the company’s stock, valued at approximately $53,629. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link.

Baxano Surgical (NASDAQ:BAXS) opened at 0.362 on Thursday. Baxano Surgical has a 52 week low of $0.36 and a 52 week high of $1.99. The stock has a 50-day moving average of $0.49 and a 200-day moving average of $0.85. The company’s market cap is $17.6 million.

Baxano Surgical (NASDAQ:BAXS) last posted its quarterly earnings results on Tuesday, August 5th. The company reported ($0.18) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.14) by $0.04. Analysts expect that Baxano Surgical will post $-0.58 EPS for the current fiscal year.

Baxano Surgical Inc, formerly TranS1 Inc, is a medical device company focused on designing, developing and marketing products that implement its approach to treat degenerative conditions of the spine affecting the lower lumbar region.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.